Incyte Corporation INCY

122.92 (1.90) (1.52%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
1,105.72 1,536.22 1,881.88 2,158.76 2,666.70 2,986.27 3,394.64 3,695.65 4,241.22 5,141.24
Revenue Growth
46.70% 38.93% 22.50% 14.71% 23.53% 11.98% 13.67% 8.87% 14.76% 21.22%
Cost of Revenue
58.19 79.48 94.12 114.25 131.33 150.99 207.00 254.99 312.07 372.13
Gross Profit
1,047.53 1,456.74 1,787.76 2,044.51 2,535.37 2,835.28 3,187.64 3,440.66 3,929.15 4,769.11
R&D Expenses
581.86 1,326.13 1,197.96 1,154.11 2,215.94 1,458.18 1,585.94 1,627.59 2,606.85 2,050.15
SG&A Expenses
303.25 366.29 434.41 468.71 516.92 739.56 1,002.14 1,155.66 1,242.16 1,376.21
Operating Income
145.00 (243.39) 129.22 402.01 (263.68) 585.78 579.44 620.52 61.37 1,514.86
Non-operating Income/Expense
(37.59) (68.90) (13.88) 84.79 31.46 (15.33) (50.32) 213.69 255.26 149.59
Non-operating Interest Expenses
38.75 6.90 1.54 1.86 2.17 1.91 2.67 2.55 2.28 2.43
EBT
107.40 (312.29) 115.35 486.79 (232.22) 570.44 529.12 834.22 316.63 1,664.45
Income Tax Provision
3.18 0.85 5.85 39.89 63.48 (378.14) 188.46 236.62 284.02 377.80
Income after Tax
104.22 (313.14) 109.49 446.91 (295.70) 948.58 340.66 597.60 32.62 1,286.65
Dividends (Preferred)
— — — 0.00 — 0.00 0.00 — 0.00 —
Net Income Common
104.22 (313.14) 109.49 446.91 (295.70) 948.58 340.66 597.60 32.62 1,286.65
EPS (Basic)
0.55 (1.53) 0.52 2.08 (1.36) 4.30 1.53 2.67 0.16 6.59
EPS (Diluted)
0.54 (1.53) 0.51 2.05 (1.36) 4.27 1.52 2.65 0.15 6.41
Shares (Basic, Weighted)
187.87 204.58 212.38 214.91 218.07 220.43 222.00 223.63 207.11 195.20
Shares (Diluted, Weighted)
194.13 204.58 215.64 217.66 218.07 222.07 223.96 225.93 210.53 200.70
Gross Margin
94.74% 94.83% 95.00% 94.71% 95.08% 94.94% 93.90% 93.10% 92.64% 92.76%
EBIT Margin
13.11% (15.84%) 6.87% 18.62% (9.89%) 19.62% 17.07% 16.79% 1.45% 29.46%
EBT margin
9.71% (20.33%) 6.13% 22.55% (8.71%) 19.10% 15.59% 22.57% 7.47% 32.37%
Net Profit Margin
9.43% (20.38%) 5.82% 20.70% (11.09%) 31.76% 10.04% 16.17% 0.77% 25.03%
Free Cash Flow Margin
16.68% (13.28%) 13.96% 29.30% (11.70%) 19.04% 26.28% 12.15% 5.54% 25.86%
EBITDA
203.42 (191.21) 184.19 456.54 (211.87) 643.62 647.29 703.18 150.61 1,608.15
EBIT
145.00 (243.39) 129.22 402.01 (263.68) 585.78 579.44 620.52 61.37 1,514.86
Income from Continuous Operations
104.22 (313.14) 109.49 446.91 (295.70) 948.58 340.66 597.60 32.62 1,286.65
Consolidated Net Income/Loss
104.22 (313.14) 109.49 446.91 (295.70) 948.58 340.66 597.60 32.62 1,286.65
EPS (Basic, from Continuous Ops)
0.55 (1.53) 0.52 2.08 (1.36) 4.30 1.53 2.67 0.16 6.59
EPS (Basic, Consolidated)
0.55 (1.53) 0.52 2.08 (1.36) 4.30 1.53 2.67 0.16 6.59
EPS (Diluted, from Cont. Ops)
0.54 (1.53) 0.51 2.05 (1.36) 4.27 1.52 2.65 0.15 6.41
Shares (Diluted, Average)
194.13 204.58 215.64 217.66 218.07 222.07 223.96 225.93 210.53 200.70
EPS (Diluted, Consolidated)
0.54 (1.53) 0.51 2.05 (1.36) 4.27 1.52 2.65 0.15 6.41
EBITDA Margin
18.40% (12.45%) 9.79% 21.15% (7.94%) 21.55% 19.07% 19.03% 3.55% 31.28%
Operating Cash Flow Margin
27.56% (6.05%) 17.87% 32.92% (4.67%) 25.10% 28.57% 13.43% 7.91% 27.49%

Fold the line items

In millions of $ except per-share values · columns are period end dates